PARP inhibitors and quality of life in ovarian cancer

被引：20

作者：

Aoki, Daisuke ^{[1
]}

Chiyoda, Tatsuyuki ^{[1
]}

机构：

[1] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan

来源：

LANCET ONCOLOGY | 2018年 / 19卷 / 08期

关键词：

D O I：

10.1016/S1470-2045(18)30435-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1012 / 1014

页数：4

共 9 条

[1] Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [J].

Bryant, HE ;

Schultz, N ;

Thomas, HD ;

Parker, KM ;

Flower, D ;

Lopez, E ;

Kyle, S ;

Meuth, M ;

Curtin, NJ ;

Helleday, T .

NATURE, 2005, 434 (7035) :913-917

[2] Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].

Farmer, H ;

McCabe, N ;

Lord, CJ ;

Tutt, ANJ ;

Johnson, DA ;

Richardson, TB ;

Santarosa, M ;

Dillon, KJ ;

Hickson, I ;

Knights, C ;

Martin, NMB ;

Jackson, SP ;

Smith, GCM ;

Ashworth, A .

NATURE, 2005, 434 (7035) :917-921

[3] Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy [J].

Friedlander, M. ;

Rau, J. ;

Lee, C. K. ;

Meier, W. ;

Lesoin, A. ;

Kim, J-W ;

Poveda, A. ;

Buck, M. ;

Scambia, G. ;

Shimada, M. ;

Hilpert, F. ;

King, M. T. ;

Debruyne, P. ;

Bologna, A. ;

Malander, S. ;

Monk, B. J. ;

Petru, E. ;

Calvert, P. ;

Herzog, T. J. ;

Barrett, C. ;

du Bois, A. .

ANNALS OF ONCOLOGY, 2018, 29 (03) :737-743

Friedlander, Michael ;

Gebski, Val ;

Gibbs, Emma ;

Davies, Lucy ;

Bloomfield, Ralph ;

Hilpert, Felix ;

Wenzel, Lari B. ;

Eek, Daniel ;

Rodrigues, Manuel ;

Clamp, Andrew ;

Penson, Richard T. ;

Provencher, Diane ;

Korach, Jacob ;

Huzarski, Tomasz ;

Vidal, Laura ;

Salutari, Vanda ;

Scott, Clare ;

Nicoletto, Maria Ornella ;

Tamura, Kenji ;

Espinoza, David ;

Joly, Florence ;

Pujade-Lauraine, Eric .

LANCET ONCOLOGY, 2018, 19 (08) :1126-1134

[5] Development of the Measure of Ovarian Symptoms and Treatment Concerns Aiming for Optimal Measurement of Patient-Reported Symptom Benefit With Chemotherapy for Symptomatic Ovarian Cancer [J].

King, Madeleine T. ;

Stockler, Martin R. ;

Butow, Phyllis ;

O'Connell, Rachel ;

Voysey, Merryn ;

Oza, Amit M. ;

Gillies, Kim ;

Donovan, Heidi S. ;

Mercieca-Bebber, Rebecca ;

Martyn, Julie ;

Sjoquist, Katrin ;

Friedlander, Michael L. .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (05) :865-873

[6]

Ledermann J, 2012, NEW ENGL J MED

[7] Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer [J].

Mirza, M. R. ;

Monk, B. J. ;

Herrstedt, J. ;

Oza, A. M. ;

Mahner, S. ;

Redondo, A. ;

Fabbro, M. ;

Ledermann, J. A. ;

Lorusso, D. ;

Vergote, I. ;

Ben-Baruch, N. E. ;

Marth, C. ;

Madry, R. ;

Christensen, R. D. ;

Berek, J. S. ;

Dorum, A. ;

Tinker, A. V. ;

du Bois, A. ;

Gonzalez-Martin, A. ;

Follana, P. ;

Benigno, B. ;

Rosenberg, P. ;

Gilbert, L. ;

Rimel, B. J. ;

Buscema, J. ;

Balser, J. P. ;

Agarwal, S. ;

Matulonis, U. A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) :2154-2164

[8] Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial [J].

Oza, Amit M. ;

Matulonis, Ursula A. ;

Malander, Susanne ;

Hudgens, Stacie ;

Sehouli, Jalid ;

del Campo, Josep M. ;

Berton-Rigaud, Dominique ;

Banerjee, Susana ;

Scambia, Giovanni ;

Berek, Jonathan S. ;

Lund, Bente ;

Tinker, Anna V. ;

Hilpert, Felix ;

Palacio Vazquez, Isabel ;

D'Hondt, Veronique ;

Benigno, Benedict ;

Provencher, Diane ;

Buscema, Joseph ;

Agarwal, Shefali ;

Mirza, Mansoor R. .

LANCET ONCOLOGY, 2018, 19 (08) :1117-1125

[9] Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease [J].

Wilson, M. K. ;

Pujade-Lauraine, E. ;

Aoki, D. ;

Mirza, M. R. ;

Lorusso, D. ;

Oza, A. M. ;

du Bois, A. ;

Vergote, I. ;

Reuss, A. ;

Bacon, M. ;

Friedlander, M. ;

Gallardo-Rincon, D. ;

Joly, F. ;

Chang, S. -J. ;

Ferrero, A. M. ;

Edmondson, R. J. ;

Wimberger, P. ;

Maenpaa, J. ;

Gaffney, D. ;

Zang, R. ;

Okamoto, A. ;

Stuart, G. ;

Ochiai, K. .

ANNALS OF ONCOLOGY, 2017, 28 (04) :727-732

← 1 →